HomeClinical TopicsFDA approves new multiple sclerosis drug

FDA approves new multiple sclerosis drug

Author(s):

On March 27, the U.S. Food and Drug Administration (FDA) approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content